Direct and indirect effects of a PPARγ agonist and PPARα/γ dual agonist on the liver

被引：0
|
作者：
Wilbur, K
Hawkins, E
Dana, S
Brozinick, J
Rafaeloff-Phail, R
Reifel-Miller, A
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A578 / A578
页数：1
相关论文
共 50 条
  • [21] Farglitazar -: Antidiabetic, PPARγ agonist
    Sorbera, LA
    Leeson, PA
    Martín, L
    Castañer, J
    DRUGS OF THE FUTURE, 2001, 26 (04) : 354 - 363
  • [22] Design of a partial PPARδ agonist
    Pettersson, Ingrid
    Ebdrup, Soren
    Havranek, Miroslav
    Pihera, Pavel
    Korinek, Marek
    Mogensen, John P.
    Jeppesen, Claus B.
    Johansson, Eva
    Sauerberg, Per
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4625 - 4629
  • [23] Treatment of PAH with a PPARγ agonist
    Gregory B. Lim
    Nature Reviews Cardiology, 2018, 15 : 381 - 381
  • [24] Dual PPAR/agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
    Jain, Mukul R.
    Giri, Suresh R.
    Bhoi, Bibhuti
    Trivedi, Chitrang
    Rath, Akshyaya
    Rathod, Rohan
    Ranvir, Ramchandra
    Kadam, Shekhar
    Patel, Hiren
    Swain, Prabodha
    Roy, Sib Sankar
    Das, Nabanita
    Karmakar, Eshani
    Wahli, Walter
    Patel, Pankaj R.
    LIVER INTERNATIONAL, 2018, 38 (06) : 1084 - 1094
  • [25] Treatment of PAH with a PPARγ agonist
    Lim, Gregory B.
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (07) : 381 - 381
  • [26] Minor structural modifications convert a selective PPARα agonist into a potent, highly selective PPARδ agonist
    Weigand, S
    Bischoff, H
    Dittrich-Wengenroth, E
    Heckroth, H
    Lang, D
    Vaupel, A
    Woltering, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4619 - 4623
  • [27] Efficacy and safety of ragaglitazar, a novel dual PPARα and PPARγ agonist, in patients with Type 2 diabetes
    Edsberg, B
    Strand, J
    Sandeman, D
    Skovsted, B
    DIABETOLOGIA, 2002, 45 : A232 - A233
  • [28] PPARγ and Dual PPARγ/αAgonist-Mediated Mesenchymal Tumors in Rodents: A Hypothetical Mode of Action
    Pruimboom-Brees, Ingrid
    Morton, Dan
    Kerlin, Roy
    Will, Yvonne
    Francone, Omar
    TOXICOLOGIC PATHOLOGY, 2009, 37 (01) : 126 - 126
  • [29] Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
    Maltarollo, Vinicius G.
    Togashi, Marie
    Nascimento, Alessandro S.
    Honorio, Kathia M.
    PLOS ONE, 2015, 10 (03):
  • [30] Aleglitazar, a dual PPARα and PPARγ agonist for the potential oral treatment of type 2 diabetes mellitus
    Lecka-Czernik, Beata
    IDRUGS, 2010, 13 (11) : 793 - 801
12345